Amneal Pharmaceuticals Non-GAAP EPS of 0.14 beats by 0.05, revenue of 659M beats by .97M
AMRX Stock | USD 8.39 0.07 0.84% |
Slightly above 57% of all Amneal Pharmaceuticals,'s investors are looking to take a long position. The analysis of overall sentiment of trading Amneal Pharmaceuticals, Class stock suggests that some investors are interested at this time. Amneal Pharmaceuticals,'s investing sentiment can be driven by a variety of factors including economic data, Amneal Pharmaceuticals,'s earnings reports, geopolitical events, and overall market trends.
Amneal |
Amneal Pharmaceuticals reports Q1 2024 financial results, beating expectations with Non-GAAP EPS of 0.14 and revenue of 659M .
Read at seekingalpha.com
Amneal Pharmaceuticals, Current Investor Sentiment
Panic Vs Confidence
57
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Amneal Pharmaceuticals,'s input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Amneal Pharmaceuticals, Class.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentWaiting |
Amneal Pharmaceuticals, Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Amneal Pharmaceuticals, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Amneal Pharmaceuticals, Historical Investor Sentiment
Investor biases related to Amneal Pharmaceuticals,'s public news can be used to forecast risks associated with an investment in Amneal. The trend in average sentiment can be used to explain how an investor holding Amneal can time the market purely based on public headlines and social activities around Amneal Pharmaceuticals, Class. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amneal Pharmaceuticals,'s market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amneal Pharmaceuticals, and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Amneal Pharmaceuticals, news discussions. The higher the estimate score, the more favorable the investor's outlook on Amneal Pharmaceuticals,.
Amneal Pharmaceuticals, Fundamental Analysis
We analyze Amneal Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amneal Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amneal Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Amneal Pharmaceuticals, is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Amneal Pharmaceuticals, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amneal Pharmaceuticals, stock to make a market-neutral strategy. Peer analysis of Amneal Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing Amneal Pharmaceuticals, by comparing valuation metrics with similar companies.
Peers
Amneal Pharmaceuticals, Related Equities
SLNO | Soleno Therapeutics | 5.77 | ||||
TIL | Instil Bio | 5.61 | ||||
CAPR | Capricor Therapeutics | 4.67 | ||||
BPTH | Bio Path | 2.50 | ||||
CTMX | CytomX Therapeutics | 2.30 | ||||
ASMB | Assembly Biosciences | 2.17 | ||||
ACHL | Achilles Therapeutics | 0.93 | ||||
CRNX | Crinetics Pharmaceuticals | 1.70 | ||||
MBRX | Moleculin Biotech | 3.53 |
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.